Open AccessTARGET DOSES OR TARGET PARAMETERS: WHAT IS PIVOTAL FOR CARDIOVASCULAR RISK DECREASE?
Author(s) -
С. Р. Гиляревский,
М.И. Кузьмина,
М. В. Голшмид,
Ирина Синицина,
Г. Ю. Захарова
Publication year - 2013
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2013-19-3-204-211
Subject(s) - medicine , pharmacology , drug , beta (programming language) , intensive care medicine , computer science , programming language
The article reviews the up-to-date approaches to the secondary prevention of cardiovascular complications, and the clinical situations when the target drug doses or target parameter levels are important to achieve an effect. We discuss the role of available evidence in titrating doses of angiotensin-converting enzyme inhibitors, statins and beta-blockers.